Oncology drugs recommended for PBS

The Pharmaceutical Benefits Advisory Committee has recommended the PBS listing of drugs for gastric cancer, breast cancer, leukaemia and non-Hodgkin’s lymphoma at its latest meeting.

It has recommended extending the PBS listing of trastuzumab (Herceptin) to include HER2-positive metastatic gastric cancers. The PBAC said its recommendation was due to the drug’s cost effectiveness and the “modest but potentially meaningful extension of overall survival in a